Coya Therapeutics Announces that Results from a Double-Blind Placebo-Controlled Study in Alzheimers Disease will be presented on October 29, 2024 at the Clinical Trials on Alzheimers Disease Conference in Madrid Coya Therapeutics, Inc. , a clinical-stage biotechnology company developing biologics intended to enhance regu

Coya Therapeutics Announces that Results from a Double-Blind Placebo-Controlled Study in Alzheimers Disease will be presented on October 29, 2024 at the Clinical Trials on Alzheimers Disease Conference in Madrid

COYA Stock   5.60  0.09  1.58%   
About 63% of Coya Therapeutics,'s investor base is looking to short. The analysis of the overall investor sentiment regarding Coya Therapeutics, Common suggests that many traders are alarmed. The current market sentiment, together with Coya Therapeutics,'s historical and current headlines, can help investors time the market. In addition, many technical investors use Coya Therapeutics, Common stock news signals to limit their universe of possible portfolio assets.
Coya Therapeutics, Inc. , a clinical-stage biotechnology company developing biologics intended to enhance regu

Read at businesswire.com
businesswire News
  

Coya Therapeutics, Fundamental Analysis

We analyze Coya Therapeutics,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Coya Therapeutics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Coya Therapeutics, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Return On Equity

Return On Equity Comparative Analysis

Coya Therapeutics, is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Coya Therapeutics, Common Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Coya Therapeutics, stock to make a market-neutral strategy. Peer analysis of Coya Therapeutics, could also be used in its relative valuation, which is a method of valuing Coya Therapeutics, by comparing valuation metrics with similar companies.

Peers

Coya Therapeutics, Related Equities

LTRNLantern Pharma   9.06   
0%
100.0%
INABIn8bio   7.14   
0%
78.0%
NAMSWNewAmsterdam Pharma   5.45   
0%
60.0%
CGTXCognition Therapeutics   4.17   
0%
46.0%
ABOSAcumen Pharmaceuticals   2.94   
0%
32.0%
GANXGain Therapeutics   1.69   
0%
18.0%
TERNTerns Pharmaceuticals   1.66   
0%
18.0%
HLVXHillevax   1.64   
0%
18.0%
CUECue Biopharma   1.59   
0%
17.0%
TCRXTscan Therapeutics   1.38   
0%
15.0%
CNTACentessa Pharmaceuticals   0.93   
0%
10.0%
DAWNDay One   0.16   
0%
1.0%
FENCFennec Pharmaceuticals   0.25   
2.0%
0%
INZYInozyme Pharma   0.25   
2.0%
0%
STROSutro Biopharma   2.17   
23.0%
0%
DRMADermata Therapeutics   2.67   
29.0%
0%

Complementary Tools for Coya Stock analysis

When running Coya Therapeutics,'s price analysis, check to measure Coya Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coya Therapeutics, is operating at the current time. Most of Coya Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Coya Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coya Therapeutics,'s price. Additionally, you may evaluate how the addition of Coya Therapeutics, to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Stocks Directory
Find actively traded stocks across global markets
Global Correlations
Find global opportunities by holding instruments from different markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments